Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgane Le Bras

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Oncogene|August 7, 2003
Data mining the p53 pathway in the Fugu genome: evidence for strong conservation of the apoptotic pathwayMorgane Le Bras, Karim Bensaad, Thierry Soussi
Journal of Clinical Immunology|May 22, 2003
Insights into the mitochondrial signaling pathway: what lessons for chemotherapy?Catherine Brenner, Morgane Le Bras, Guido Kroemer
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
The modulation of inter-organelle cross-talk to control apoptosisMorgane Le Bras, Isabelle Rouy, Catherine Brenner
Medecine Sciences : M/S|December 2, 2011
[RXR, a key member of the oncogenic complex in acute promyelocytic leukemia]Juliane Halftermeyer, Morgane Le Bras, Hugues De Thé
Frontiers in Oncology|July 13, 2013
PML, SUMOylation, and SenescenceLisa Ivanschitz, Hugues De Thé, Morgane Le Bras
The Journal of Cell Biology|July 11, 2012
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodiesHugues de Thé, Morgane Le Bras, Valérie Lallemand-Breitenbach
Journal of Cell Science|September 20, 2007
A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cellsWilfried Condemine, Yuki Takahashi, Morgane Le Bras, et al.
Oncogene|February 19, 2002
Monoclonal antibodies raised against Xenopus p53 interact with human p73Morgane Le Bras, Valérie Delattre, Karim Bensaad, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescenceLisa Ivanschitz, Yuki Takahashi, Florence Jollivet, et al.
Biomedicines|August 26, 2023
ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!Ghada Chamandi, Layal El-Hajjar, Abdallah El Kurdi, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Oncogene|August 7, 2003
Data mining the p53 pathway in the Fugu genome: evidence for strong conservation of the apoptotic pathwayMorgane Le Bras, Karim Bensaad, Thierry Soussi
Journal of Clinical Immunology|May 22, 2003
Insights into the mitochondrial signaling pathway: what lessons for chemotherapy?Catherine Brenner, Morgane Le Bras, Guido Kroemer
Medicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
The modulation of inter-organelle cross-talk to control apoptosisMorgane Le Bras, Isabelle Rouy, Catherine Brenner
Medecine Sciences : M/S|December 2, 2011
[RXR, a key member of the oncogenic complex in acute promyelocytic leukemia]Juliane Halftermeyer, Morgane Le Bras, Hugues De Thé
Frontiers in Oncology|July 13, 2013
PML, SUMOylation, and SenescenceLisa Ivanschitz, Hugues De Thé, Morgane Le Bras
The Journal of Cell Biology|July 11, 2012
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodiesHugues de Thé, Morgane Le Bras, Valérie Lallemand-Breitenbach
Journal of Cell Science|September 20, 2007
A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cellsWilfried Condemine, Yuki Takahashi, Morgane Le Bras, et al.
Oncogene|February 19, 2002
Monoclonal antibodies raised against Xenopus p53 interact with human p73Morgane Le Bras, Valérie Delattre, Karim Bensaad, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2015
PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescenceLisa Ivanschitz, Yuki Takahashi, Florence Jollivet, et al.
Biomedicines|August 26, 2023
ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!Ghada Chamandi, Layal El-Hajjar, Abdallah El Kurdi, et al.
Pageof 4